Jnce share price
Web14 apr. 2024 · Shares of NASDAQ:JNCE opened at $1.92 on Friday. Jounce Therapeutics has a 1 year low of $0.58 and a 1 year high of $7.23. The firm has a market capitalization of $100.11 million, a PE ratio of -0.75 and a beta of 0.75. The business's 50 day moving average price is $1.39 and its 200-day moving average price is $1.39. Web23 uur geleden · See the latest Jounce Therapeutics Inc stock price (NASDAQ:JNCE), related news, valuation, dividends and more to help you make your investing decisions.
Jnce share price
Did you know?
Web10 apr. 2024 · Jounce Therapeutics (Nasdaq:JNCE) - Stock Price, News & Analysis - Simply Wall St Stocks / United States / Pharmaceuticals & Biotech Jounce Therapeutics … Web15 mrt. 2024 · Shares Sold Short 3.18 M Change from Last -23.81% Percent of Float 7.24% Stock Money Flow N/A PROFILE ( JNCE) Jounce Therapeutics, Inc. is a clinical stage immunotherapy company, which...
Web6 apr. 2024 · The Jounce Therapeutics Inc stock price fell by -0.526% on the last day (Thursday, 6th Apr 2024) from $1.90 to $1.89. During the last trading day the stock … Web18 mrt. 2024 · JNCE Price $1.56 Fair Value Price $2,915.33 Market Cap $81.34M 52 Week Low $0.58 52 Week High $7.94 P/E -1.58x P/B 0.44x P/S 0.7x PEG N/A Dividend Yield …
Web30 mrt. 2024 · JNCE share price has been in a bull cycle for the past year. Jounce Therapeutics, Inc. stock trend is positive . Jounce Therapeutics company info … WebAt the moment, there are. 52.14M JNCE shares outstanding. The market capitalization of JNCE is $98.55M. In the past 24 hours, 1.63M JNCE shares were traded. ... Steven …
Web6 mrt. 2024 · Jounce Therapeutics Inc. (JNCE) is priced at $1.11 after the most recent trading session. At the very opening of the session, the stock price was $1.16 and reached a high price of $1.19, prior to closing the session it reached the value of $1.16.
Web12 apr. 2024 · According to the issued ratings of 5 analysts in the last year, the consensus rating for Jounce Therapeutics stock is Hold based on the current 4 hold ratings and 1 … reckon accounts hosted contact numberWeb10 apr. 2024 · Earnings estimates for 2024 have increased from $1.40 per share to $1.46 per share over the past 60 days. The company has a Zacks Rank #2 (Buy). ... Price and Consensus: JNCE . reckon accounts 2016 downloadWeb13 jul. 2024 · Jounce Therapeutics NasdaqGS:JNCE Stock Report Last Price US$1.21 Market Cap US$62.6m 7D 1.7% 1Y -84.1% Updated 04 Feb, 2024 Data Company Financials + 6 Analysts Jounce Therapeutics, Inc. NasdaqGS:JNCE Stock Report Mkt Cap: US$62.6m Add to watchlist CompanyOverview 1Valuation 2Future Growth 3Past … reckon accounts personal plus 2015 downloadWeb3 apr. 2024 · April 3, 2024. Business. In the last trading session, 1.05 million Jounce Therapeutics Inc. (NASDAQ:JNCE) shares changed hands as the company’s beta … unterricht thema waldWeb15 mrt. 2024 · The Board of Directors of Jounce Therapeutics Inc JNCE ... The Proposal consists of $1.80 in cash per share plus a contingent ... Price Action: JNCE shares are … reckon accounts plus 2017unterricht writing an emailWeb14 apr. 2024 · The shares were bought at an average cost of $0.99 per share, for a total transaction of $65,043.99. Following the purchase, the insider now owns 5,279,801 shares of the company’s stock, valued ... reckon activation code